{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-24-005990","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.382061+00:00","generated_at":"2026-06-02T02:08:46.462342+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tonix reports Q1 net loss $14.9M; cash at $7.0M; advancing Tonmya NDA","bullets":["Net product revenue $2.5M from Zembrace/Tosymra; net loss $(14.9)M ($0.18/share) vs $(33.0)M ($3.21) YoY.","Cash $7.0M at Mar 31, 2024, down from $24.9M Dec 31; net cash used in ops $17.6M.","On track to submit NDA for Tonmya in H2 2024; pre-NDA FDA meeting scheduled Q2 2024.","Raised $4.4M in registered direct offering on Apr 1, 2024 (post-quarter).","R&D expenses down to $12.9M from $26.5M; G&A up to $9.3M from $7.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-24-005990","json":"https://secwatch.observer/filing/0001999371-24-005990.json","markdown":"https://secwatch.observer/filing/0001999371-24-005990.md","text":"https://secwatch.observer/filing/0001999371-24-005990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124005990/0001999371-24-005990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124005990/tnpx_8k-051324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:08:46.462342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b25d702ab13260019efbfd95dd1f7b0d35d8bd0","claim":"Tonix Pharmaceuticals Holding Corp. reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On May 13, 2024, Tonix Pharmaceuticals Holding Corp. (the “Company”) announced its operating results for the quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124005990/0001999371-24-005990-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}